Profile
Paul Cox is currently Senior Associate at Stern Investor Relations, Inc. since 2011, VP-Investor Relations & Corporate Communications at Dynavax Technologies Corp.
since 2023, and Head-Investor Relations & Communications at BioNTech US, Inc. Former positions include President & Director-Boston Chapter at National Investor Relations Institute, Head-Investor Relations at SAGE Therapeutics, Inc., Vice President-Investor Relations at Voyager Therapeutics, Inc. from 2019 to 2020, and Vice President-Investor Relations & Communications at Kymera Therapeutics, Inc. Education includes undergraduate studies at the University of Massachusetts and graduate studies at Harvard Extension School.
Paul Cox active positions
| Companies | Position | Start |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Investor Relations Contact | 2023-02-28 |
| NEON THERAPEUTICS, INC. | Investor Relations Contact | - |
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Provides investor relations services to healthcare and biotechnology companies | Corporate Officer/Principal | 2010-12-31 |
Former positions of Paul Cox
| Companies | Position | End |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Investor Relations Contact | 2020-10-31 |
| SAGE THERAPEUTICS, INC. | Investor Relations Contact | 2019-02-28 |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Corporate Officer/Principal | - |
| KYMERA THERAPEUTICS, INC. | Investor Relations Contact | - |
Training of Paul Cox
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Dynavax Technologies Corp.
Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services Operates as a association for corporate officers and investors | Commercial Services |
SAGE Therapeutics, Inc.
SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Provides investor relations services to healthcare and biotechnology companies | Finance |
Harvard Extension School
Harvard Extension School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNTech US, Inc.
BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
- Stock Market
- Insiders
- Paul Cox
















